drugset / Trial / NCT01085175
Trial to Determine Imaging Parameters of LMI1195 in Heart Failure Patients at Low and High Risk of Defibrillator Firing
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
The purpose of this clinical study is to determine the optimal imaging parameters and assess the safety of LMI1195 -101 in Heart Failure subjects at Low and High Risk of cardiac events.
Timeline
- Start
- 2010-05
- Primary completion
- 2011-02
- Completion
- 2011-02
Outcome
Outcome not reported
Stopped: “Sponsor is re-evaluating the clinical development path”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FLUBROBENGUANE | Small molecule | — | Intravenous |